Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
about
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.Leukemic manifestation of blastic plasmacytoid dendritic cell neoplasm: laboratory approaches in 2 cases.Neoplasms derived from plasmacytoid dendritic cells.Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells.
P2860
Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Immunohistochemical analysis o ...... ytoid dendritic cell neoplasm.
@en
Immunohistochemical analysis o ...... ytoid dendritic cell neoplasm.
@nl
type
label
Immunohistochemical analysis o ...... ytoid dendritic cell neoplasm.
@en
Immunohistochemical analysis o ...... ytoid dendritic cell neoplasm.
@nl
prefLabel
Immunohistochemical analysis o ...... ytoid dendritic cell neoplasm.
@en
Immunohistochemical analysis o ...... ytoid dendritic cell neoplasm.
@nl
P2093
P2860
P356
P1433
P1476
Immunohistochemical analysis o ...... ytoid dendritic cell neoplasm.
@en
P2093
Chan-Jeoung Park
Cheolwon Suh
Hyun-Sook Chi
Je Hwan Lee
Joo-Ryung Huh
Keumrock Hwang
Kyoo Hyung Lee
Seongsoo Jang
P2860
P304
P356
10.1111/HIS.12079
P577
2013-03-07T00:00:00Z